跳至主要内容
临床试验/CTRI/2024/07/071650
CTRI/2024/07/071650招募中不适用

Hospital Based Cancer Registry

ICMR-NCDIR1 个研究点 分布在 1 个国家目标入组 200,000 人开始时间: 2024年8月10日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200,000
试验地点
1
主要终点
1. To describe the profile and patterns of cancer in patients availing of care at the reporting hospital.

研究概览

简要总结

In 2020, there were an estimated 1.39 million cancers in India. Cancer surveillance is an essential part of cancer prevention and control efforts. The specific objectives of this project    include describing the cancer types clinical, pathological, and treatment-related details and outcomes among cancer patients availing of care. Data on cancer patients will be collected from all the cancer diagnosing and treating departments at a hospital, using a standardized core form. A specially designed software will be used for data quality checks and data transmission to NCDIR, for further analysis and dissemination. The findings from hospital based registry will help to assess the patterns and quality of cancer care at specific hospitals, and reflect on the health system performance on cancer related diagnosis and treatment. It will also help in the planning of health services, resource allocation and evaluation of cancer care services.

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • All Neoplasms with a behavior code of 3 as defined by the International Classification of Diseases for Oncology 3rd edition will be recruited.
  • Cancer from all sites with a confirmatory diagnosis
  • Participants of all age groups will be recruited.

排除标准

  • Any neoplasm with a behavior code of <3 will be excluded.

结局指标

主要结局

1. To describe the profile and patterns of cancer in patients availing of care at the reporting hospital.

时间窗: 12 weeks

2. To contribute data on cancer patients to the respective PBCRs in India under ICMR- NCDIR-NCRP.

时间窗: 12 weeks

次要结局

  • Screen eligible patients & abstract medical records to describe the diagnostic, staging, & treatment details of the cancer patients.(24 weeks)

研究者

发起方
ICMR-NCDIR
申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Dr. Bhawna Sirohi

BALCO medical Center

研究点 (1)

Loading locations...

相似试验